Literature DB >> 1371330

Potentiation of NMDA receptor currents by arachidonic acid.

B Miller1, M Sarantis, S F Traynelis, D Attwell.   

Abstract

Arachidonic acid is released by phospholipase A2 when activation of N-methyl-D-aspartate (NMDA) receptors by neurotransmitter glutamate raises the calcium concentration in neurons, for example during the initiation of long-term potentiation and during brain anoxia. Here we investigate the effect of arachidonic acid on glutamate-gated ion channels by whole-cell clamping isolated cerebellar granule cells. Arachidonic acid potentiates, and makes more transient, the current through NMDA receptor channels, and slightly reduces the current through non-NMDA receptor channels. Potentiation of the NMDA receptor current results from an increase in channel open probability, with no change in open channel current. We observe potentiation even with saturating levels of agonist at the glutamate- and glycine-binding sites on these channels; it does not result from conversion of arachidonic acid to lipoxygenase or cyclooxygenase derivatives, or from activation of protein kinase C. Arachidonic acid may act by binding to a site on the NMDA receptor, or by modifying the receptor's lipid environment. Our results suggest that arachidonic acid released by activation of NMDA (or other) receptors will potentiate NMDA receptor currents, and thus amplify increases in intracellular calcium concentration caused by glutamate. This may explain why inhibition of phospholipase A2 blocks the induction of long-term potentiation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1371330     DOI: 10.1038/355722a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  107 in total

1.  Serum constituents can affect 2'-& 3'-O-(4-benzoylbenzoyl)-ATP potency at P2X(7) receptors.

Authors:  A D Michel; M Xing; P P Humphrey
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

Review 2.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

3.  Effects of arachidonic acid on unitary calcium currents in rat sympathetic neurons.

Authors:  L Liu; A R Rittenhouse
Journal:  J Physiol       Date:  2000-06-01       Impact factor: 5.182

4.  Arachidonic acid inhibits transient potassium currents and broadens action potentials during electrographic seizures in hippocampal pyramidal and inhibitory interneurons.

Authors:  S Keros; C J McBain
Journal:  J Neurosci       Date:  1997-05-15       Impact factor: 6.167

Review 5.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

6.  Modulation of acid-sensing ion channels: molecular mechanisms and therapeutic potential.

Authors:  Xiang-Ping Chu; Christopher J Papasian; John Q Wang; Zhi-Gang Xiong
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2011-11-18

Review 7.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

8.  Arachidonic acid stimulates a novel cocaine-sensitive cation conductance associated with the human dopamine transporter.

Authors:  S L Ingram; S G Amara
Journal:  J Neurosci       Date:  2000-01-15       Impact factor: 6.167

9.  Glutamate stably enhances the activity of two cytosolic forms of phospholipase A2 in brain cortical cultures.

Authors:  D K Kim; G Rordorf; R A Nemenoff; W J Koroshetz; J V Bonventre
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

Review 10.  Acid-sensing ion channels in pathological conditions.

Authors:  Xiang-Ping Chu; Zhi-Gang Xiong
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.